[1]Ghattas A, Griffiths H R, Devitt A, et al. Monocytes in coronary artery disease and atherosclerosis where are we now[J].J Am Coll Cardiol,2013,62(17):1541 [2]Hafiane A, Genest J. High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk[J]. BBA Clin, 2015, 3: 175 [3]Kanbay M, Solak Y, Unal H U, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease[J].Int Urol Nephrol,2014,46(8):1619 [4]Austen W G, Edwards J E, Frye R L, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association[J].Circulation,1975,51(4 Suppl):5 [5]中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中国医学前沿杂志:电子版,2011,3(5):42 [6]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J].中国医学前沿杂志:电子版,2015,6(3):26 [7]Gensini G G. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51(3):606 [8]Libby P. Inflammation in atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2002,420(6917):868 [9]Yu X H, Fu Y C, Zhang D W, et al. Foam cells in atherosclerosis [J]. Clin Chim Acta, 2013, 424: 245 [10]Jaipersad A S, Lip G Y, Silverman S A. The role of monocytes in angiogenesis and atherosclerosis[J].J Am Coll Cardiol,2014,63(1):1 [11]Gratchev A, Sobenin I, Orekhov A, et al. Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology, 2012, 217(5): 476 [11]Gratchev A, Sobenin I, Orekhov A A. Monocytes as a diagnostic marker of cardiovascular diseases[J].Immunobiology,2012,217(5, SI):476 [12]Berrougui H, Momo C N, Khalil A. Health benefits of high-density lipoproteins in preventing cardiovascular diseases[J].J Clin Lipidol,2012,6(6):524 [13]Murphy A J, Westerterp M, Yvan-Charvet L A. Anti-atherogenic mechanisms of high density lipoprotein: Effects on myeloid cells[J]. Biochim Biophys Acta,2012,1821(3, SI):513
[1]陈 云,袁如玉,阎哲慧,等.动态动脉硬化指数对原发性高血压患者冠心病的预测价值[J].天津医科大学学报,2013,19(06):468.
CHEN Yun,YUAN Ru-yu,YAN Zhe-hui,et al.Predictive value of ambulatory arterial stiffness index for coronary heart disease in primary hypertensive patients[J].Journal of Tianjin Medical University,2013,19(02):468.
[2]蒋森森,周长钰.平均血小板体积、红细胞分布宽度与冠心病的相关性研究[J].天津医科大学学报,2014,20(02):120.
JIANG Sen-sen,ZHOU Chang-yu.Correlation between mean platelet volume, red blood cell distribution width and coronary heart disease [J].Journal of Tianjin Medical University,2014,20(02):120.
[3]巩江华,周长钰.RT-3DE在评价冠状动脉病变中的价值[J].天津医科大学学报,2014,20(02):131.
GONG Jiang-hua,ZHOU Chang-yu.Evaluation of coronary artery stenosis by using real-time three-dimensional echocardiography[J].Journal of Tianjin Medical University,2014,20(02):131.
[4]彭云玲,齐 新,魏丽萍,等.冠心病心力衰竭患者心率变异性分析[J].天津医科大学学报,2014,20(05):363.
PENG Yun-ling,QI Xin,WEI Li-ping,et al.Analysis on heart rate variability in heart failure patients with coronary heart disease[J].Journal of Tianjin Medical University,2014,20(02):363.
[5]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[6]李佳丽,姚朱华,马 梅,等.冠心病合并阻塞性睡眠呼吸暂停低通气综合征临床分析[J].天津医科大学学报,2014,20(06):472.
[7]陈 丹,王小东,童静植,等. 三种分离人外周血单核细胞方法的比较[J].天津医科大学学报,2014,20(06):483.
CHEN Dan,WANG Xiao-dong,TONG Jing-zhi,et al.Comparison of three methods of separating human peripheral blood mononuclear cells [J].Journal of Tianjin Medical University,2014,20(02):483.
[8]刘洪梅综述,李广平审校. 血清胆红素在冠心病患者中的应用价值研究进展[J].天津医科大学学报,2014,20(06):506.
[9]刘 瑞,刘玉洁,何 乐.CETP TaqIB基因多态性与血脂及冠心病相关性研究[J].天津医科大学学报,2015,21(02):117.
LIU Rui,LIU Yu-jie,HE Le.Studies on the correlation between CETP TaqIB gene polymorphism and blood lipid and coronary heart disease[J].Journal of Tianjin Medical University,2015,21(02):117.
[10]李文军,刘相丽,孙丽丽,等.血清胱抑素C在急性冠脉综合征中的预测价值[J].天津医科大学学报,2015,21(03):189.
LI Wen-jun,LIU Xiang-li,SUN Li-li,et al.Prediction value of plasma cystatin C level in patients with acute coronary syndrome[J].Journal of Tianjin Medical University,2015,21(02):189.